Foley Hoag LLP announced that Carmen DeMatteis has joined the firm as a Partner in its Emerging Company and Venture Capital practice group.
DeMatteis brings over a decade of experience guiding emerging companies and investors on venture capital financings, domestic and international mergers and acquisitions, joint ventures, and general corporate counseling.
"Carmen's skillset is a perfect fit for the needs of our emerging company and venture capital clients in New York and beyond," said practice group Co-Chair Chip Korn. "Her time spent in-house coupled with her active practice supporting a client's full life cycle further illustrates Foley Hoag's commitment to provide best-in-class services to the global entrepreneurial community."
DeMatteis was previously in the Tech Group at the New Jersey office of Lowenstein Sandler LLP, where she had started her career in 2007. She also served as Chief Counsel, Corporate and M&A, at global medical device company Cantel Medical Corp. (since acquired by Steris), where she led M&A transactions and handled corporate governance and international restructuring projects.
Pitchbook's most recent global league tables ranked Foley Hoag among the 20 most active law firms for venture financings in the U.S., and across 10 additional categories in the U.S. and globally. The firm also received a Tier 1 ranking for Venture Capital Law in the 2023 edition ofU.S. News – Best Lawyers"Best Law Firms."